BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 32096658)

  • 1. Primary lymph node sites in Hodgkin lymphoma and the risk of second primary cancers: a population-based study.
    Ebied A; Yousif M; Nam NH; Elhamamsy AR; Hassan OG; Mostafa EM; Nguyen GJ; Hirayama K; Huy NT
    Future Oncol; 2020 Mar; 16(9):451-467. PubMed ID: 32096658
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of primary lymph node sites in survival and mortality prediction in Hodgkin lymphoma: a SEER population-based retrospective study.
    Ebied A; Thanh Huan V; Makram OM; Sang TK; Ghorab M; Ngo HT; Iraqi A; Kamel MG; Dang TN; Vuong NL; Hirayama K; Huy NT
    Cancer Med; 2018 Apr; 7(4):953-965. PubMed ID: 29520977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma.
    Kumar V; Garg M; Chandra AB; Mayorga VS; Ahmed S; Ailawadhi S
    Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):576-589.e1. PubMed ID: 29934060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
    Ali S; Olszewski AJ
    Leuk Lymphoma; 2014 Jul; 55(7):1570-7. PubMed ID: 24067135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
    Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
    Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma.
    Chang ET; Lau EC; Mowat FS; Teta MJ
    Cancer Causes Control; 2017 Sep; 28(9):971-979. PubMed ID: 28755241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.
    Hodgson DC; Gilbert ES; Dores GM; Schonfeld SJ; Lynch CF; Storm H; Hall P; Langmark F; Pukkala E; Andersson M; Kaijser M; Joensuu H; Fosså SD; Travis LB
    J Clin Oncol; 2007 Apr; 25(12):1489-97. PubMed ID: 17372278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
    Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
    Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
    Amber KT; Bloom R; Nouri K
    Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma.
    Chowdhry AK; Fung C; Chowdhry VK; Bergsma D; Dhakal S; Constine LS; Milano MT
    Leuk Lymphoma; 2018 May; 59(5):1180-1187. PubMed ID: 28862484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
    Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
    Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients.
    Milano MT; Li H; Constine LS; Travis LB
    Cancer; 2011 Dec; 117(24):5538-47. PubMed ID: 21692074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
    Shah BK; Khanal A
    Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
    Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
    J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
    Abdel-Rahman O
    Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four Lymphomas in 1 Patient: A Unique Case of Triple Composite Non-Hodgkin Lymphoma Followed by Classical Hodgkin Lymphoma.
    Tennese A; Skrabek PJ; Nasr MR; Sekiguchi DR; Morales C; Brown TC; Weisenburger DD; Perry AM
    Int J Surg Pathol; 2017 May; 25(3):276-280. PubMed ID: 27688525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
    Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
    J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Treatment for Hodgkin Lymphoma With Estrogen Receptor Status of Subsequent Breast Cancers.
    Withrow DR; Morton LM; Curtis RE; Schonfeld SJ; Berrington de González A
    JAMA Oncol; 2018 Mar; 4(3):414-416. PubMed ID: 29346498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.